Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: February 12, 2026
Reporting Period: Quarter ended December 31, 2025
This filing announces the financial results for the quarter ended December 31, 2025. The report incorporates by reference a press release (Exhibit 99.1) and a Supplemental Earnings Presentation (Exhibit 99.2) posted to the company's Investor Relations website.
Key Financial Metrics
The provided text serves as a cover document referencing external exhibits for detailed data. Consequently, the filing text does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) and Supplemental Earnings Presentation (Exhibit 99.2) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing directs readers to the Supplemental Earnings Presentation for detailed management commentary and financial analysis.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in this report, including the exhibits, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific revenue and earnings figures in the press release (Exhibit 99.1) dated February 12, 2026.
- Review the Supplemental Earnings Presentation (Exhibit 99.2) for segment performance and margin analysis.
- Confirm any forward-looking guidance or outlook statements contained within the referenced exhibits.
- Check the company's Investor Relations website at www.bio-rad.com for the full presentation materials.